These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18046295)

  • 21. Recombinant human activated protein C.
    Hughes M
    Int J Antimicrob Agents; 2006 Aug; 28(2):90-4. PubMed ID: 16837170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical impact of novel anticoagulation strategies in sepsis.
    Opal SM
    Curr Opin Crit Care; 2001 Oct; 7(5):347-53. PubMed ID: 11805532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sepsis update: management of severe sepsis and septic shock in the emergency department after the withdrawal of Xigris.
    Green RS; Djogovic D; Howes D
    CJEM; 2012 Sep; 14(5):265-9. PubMed ID: 22967692
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant human activated protein C and strict glycemic control in sepsis: mutually exclusive strategies?
    Schultz MJ; Levi M
    Minerva Anestesiol; 2009; 75(7-8):415-6. PubMed ID: 19153552
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of activated protein C (drotrecogin alfa) in a patient with sepsis and respiratory failure on ultra high frequency jet ventilation.
    Datta D; McNamee M
    Conn Med; 2003 Jan; 67(1):11-2. PubMed ID: 12630184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activated protein C in sepsis: a critical review.
    Levi M
    Curr Opin Hematol; 2008 Sep; 15(5):481-6. PubMed ID: 18695371
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Activated protein C, coagulation, inflammation, and treatment of severe sepsis].
    van Deventer SJ; Pajkrt D
    Ned Tijdschr Geneeskd; 2001 Mar; 145(13):613-6. PubMed ID: 11305209
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paving a new road for generating evidence-based care in sepsis*.
    Annane D
    Crit Care Med; 2014 Jul; 42(7):1743-4. PubMed ID: 24933058
    [No Abstract]   [Full Text] [Related]  

  • 29. The next generation of sepsis clinical trial designs: what is next after the demise of recombinant human activated protein C?*.
    Opal SM; Dellinger RP; Vincent JL; Masur H; Angus DC
    Crit Care Med; 2014 Jul; 42(7):1714-21. PubMed ID: 24717456
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of sepsis in the surgical intensive care unit.
    Carney DE; Matsushima K; Frankel HL
    Isr Med Assoc J; 2011 Nov; 13(11):694-9. PubMed ID: 22279706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness of treatments for severe sepsis: data from the bundle implementation programs.
    Ferrer R; Artigas A
    Minerva Anestesiol; 2011 Mar; 77(3):360-5. PubMed ID: 21441890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Why are we still mesmerized by the old fashioned Medicine Man?
    Silvestri L; Rommes JH; Petros AJ; De La Cal MA; Taylor N; Van Saene HK
    Minerva Anestesiol; 2012 Dec; 78(12):1415. PubMed ID: 22672931
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical experience with drotrecogin alfa in treating gram-positive and -negative pathogens in patients with severe sepsis.
    Cone LA; Stone RA; Jesser K; Nelson R
    J Investig Med; 2004 Nov; 52(7):470-4. PubMed ID: 15651264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A blueprint for a sepsis protocol.
    Shapiro NI; Howell M; Talmor D
    Acad Emerg Med; 2005 Apr; 12(4):352-9. PubMed ID: 15805328
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Xigris and corticoids: what are the perspectives for the patient with severe sepsis?].
    Annane D
    Ann Fr Anesth Reanim; 2003 Dec; 22 Spec No 1():43-5. PubMed ID: 15359943
    [No Abstract]   [Full Text] [Related]  

  • 36. Xigris: reducing mortality in adult patients with severe sepsis.
    Larson AM
    Urol Nurs; 2002 Jun; 22(3):200-1. PubMed ID: 12087796
    [No Abstract]   [Full Text] [Related]  

  • 37. Activated protein C (Xigris): a drug in trouble.
    Vangerow B; Mignini MA
    Acta Anaesthesiol Scand; 2007 Feb; 51(2):261-2. PubMed ID: 17261152
    [No Abstract]   [Full Text] [Related]  

  • 38. An opinion too far--the campaign against the Surviving Sepsis Campaign.
    Barie PS
    Surg Infect (Larchmt); 2006 Dec; 7(6):485-8. PubMed ID: 17233565
    [No Abstract]   [Full Text] [Related]  

  • 39. [Can we still afford progress in intensive care medicine? Re: the article from DMW 1-2/2004].
    Kalenka A
    Dtsch Med Wochenschr; 2004 Jul; 129(31-32):1698-9; author reply 1699-70. PubMed ID: 15273924
    [No Abstract]   [Full Text] [Related]  

  • 40. [Human recombinant activated protein C in patients with severe sepsis and septic shock].
    Segal E
    Harefuah; 2002 Feb; 141(2):130-1. PubMed ID: 11905079
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.